A massive retrospective analysis of over 83,000 emergency colorectal surgeries from the ACS-NSQIP database (2012–2021) shows robotic-assisted surgery significantly outperforms both laparoscopic and open approaches in select cases. Robotic procedures had fewer surgical complications, a shorter hospital stay, and far lower conversion rates to open surgery (7.8% vs. 24.2%). Adoption of robotic platforms grew from 0% to 6.6% during the study period—and is projected to rise to over 20% by 2025. While robotic surgery is typically reserved for clinically stable patients—such as those with diverticulitis or non-septic cancer—it’s increasingly seen as a viable option even in emergency settings.
Author: Abhay Panchal
Olympus and Revival Healthcare Capital have launched Swan EndoSurgical, a U.S.-based venture developing a next-gen endoluminal robot for minimally invasive GI procedures.Designed to overcome limitations of manual scopes, the flexible-armed platform may expand global access to advanced therapeutic endoscopy.
Two major reviews from Dana-Farber Cancer Institute spotlight a global surge in gastrointestinal (GI) cancers among adults under 50—with colorectal cancer leading the trend, followed by pancreatic, gastric, and esophageal cancers. Published in JAMA and the British Journal of Surgery, the findings highlight steep increases among younger age groups, especially those born after 1990.
In a sweeping 900-page proposal, CMS plans to eliminate the Inpatient Only (IPO) list over 3 years, starting with 285 procedures in 2026—mostly musculoskeletal—and add 547 procedures to the Ambulatory Surgery Center Covered Procedures List (ASC-CPL). The goal: expand outpatient surgical access and lower patient costs. Key updates include:
AGA presents a new season of Inside Scope based off the Perspectives column from our newspaper, GI & Hepatology News. In this series, we’ll feature guests debating or offering complementary opinions on current hot topics in GI. In this episode, filmed live at Digestive Disease Week® (DDW) 2025, GI & Hepatology News editor Gyanprakash A. Ketwaroo, MD, MSc, hosts a discussion with Moamen Gabr, MD, MSC and Jeffrey D. Mosko, MD, MSc on the best practices for removing large or complex colon polyps.
MedCore Partners and GI Alliance have opened a new Ambulatory Surgery Center and managed clinic in Kansas City, designed for high-quality, outpatient GI care. The facility features advanced surgical suites, integrated tech, and seamless care coordination. This marks another strategic move by GI Alliance—now over 1,000 gastroenterologists strong—as it scales its national footprint through physician-led, state-of-the-art GI facilities.
Doximity has launched a free, HIPAA-compliant AI medical scribe available to all verified U.S. clinicians, undercutting high-cost competitors. The tool integrates seamlessly with its Dialer platform and aims to reduce burnout, especially in underserved clinics. With 80% of U.S. physicians on its network, Doximity is poised to reshape the ambient documentation space.
2025 is bringing a wave of groundbreaking advancements in gastrointestinal care, with emerging technologies that aim to improve GI diagnoses, reduce recovery times and offer more effective treatments for patients. From AI integration to minimally invasive procedures, here are eight breakthroughs shaping the future of GI care.
🚻 Key Insights
While deal volume in gastroenterology has declined—down from 27 deals in 2022 to just 11 in 2024—the fundamentals for consolidation remain strong. KPMG’s Q1 2025 report makes one thing clear: GI remains a highly fragmented, growth-ready specialty that continues to attract private equity and strategic buyers. What’s driving this evolution? Why this matters:The drop in deal count doesn’t signal weakness—it reflects a maturing landscape where quality, not quantity, defines activity. Practices that modernize and offer scalable infrastructure are best positioned to capitalize on future waves of consolidation.